Bruce Jackson
Stock Analyst at Benchmark
(0.86)
# 3,796
Out of 4,931 analysts
124
Total ratings
25.21%
Success rate
-26.2%
Average return
Main Sectors:
Stocks Rated by Bruce Jackson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CV CapsoVision | Initiates: Speculative Buy | $5 | $4.29 | +16.55% | 1 | Jul 28, 2025 | |
| BFRI Biofrontera | Maintains: Buy | $7 → $2.75 | $0.95 | +189.47% | 8 | May 19, 2025 | |
| HUMA Humacyte | Maintains: Buy | $17 → $14 | $2.47 | +466.80% | 15 | May 14, 2025 | |
| HBIO Harvard Bioscience | Maintains: Speculative Buy | $4.5 → $3 | $0.51 | +483.54% | 6 | May 13, 2025 | |
| CLNN Clene | Maintains: Buy | $84 → $33 | $3.67 | +799.18% | 8 | May 8, 2025 | |
| GNLX Genelux | Maintains: Speculative Buy | $25 → $23 | $3.34 | +588.62% | 7 | May 8, 2025 | |
| BLTE Belite Bio | Reiterates: Buy | $80 | $70.09 | +14.14% | 9 | Mar 26, 2025 | |
| NEO NeoGenomics | Reiterates: Hold | n/a | $5.76 | - | 8 | Jan 16, 2025 | |
| EXAS Exact Sciences | Reiterates: Buy | $65 | $43.16 | +50.60% | 7 | Jan 13, 2025 | |
| VNRX VolitionRx | Reiterates: Hold | n/a | $0.64 | - | 3 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $30 | $4.06 | +638.92% | 8 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $1.25 | $0.60 | +106.65% | 2 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $3 | $1.25 | +140.00% | 3 | Oct 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $5 | $1.86 | +168.82% | 4 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $30 | $0.63 | +4,646.84% | 2 | Sep 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $60 | $3.87 | +1,450.39% | 5 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $17 | $0.43 | +3,865.48% | 4 | Aug 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $24 | $1.35 | +1,677.78% | 3 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $1 | $2.39 | -58.16% | 2 | May 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $5 | $0.73 | +581.11% | 4 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.59 | - | 7 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $26.95 | - | 7 | Sep 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Speculative Buy | $800 | $3.54 | +22,498.87% | 1 | Aug 8, 2022 |
CapsoVision
Jul 28, 2025
Initiates: Speculative Buy
Price Target: $5
Current: $4.29
Upside: +16.55%
Biofrontera
May 19, 2025
Maintains: Buy
Price Target: $7 → $2.75
Current: $0.95
Upside: +189.47%
Humacyte
May 14, 2025
Maintains: Buy
Price Target: $17 → $14
Current: $2.47
Upside: +466.80%
Harvard Bioscience
May 13, 2025
Maintains: Speculative Buy
Price Target: $4.5 → $3
Current: $0.51
Upside: +483.54%
Clene
May 8, 2025
Maintains: Buy
Price Target: $84 → $33
Current: $3.67
Upside: +799.18%
Genelux
May 8, 2025
Maintains: Speculative Buy
Price Target: $25 → $23
Current: $3.34
Upside: +588.62%
Belite Bio
Mar 26, 2025
Reiterates: Buy
Price Target: $80
Current: $70.09
Upside: +14.14%
NeoGenomics
Jan 16, 2025
Reiterates: Hold
Price Target: n/a
Current: $5.76
Upside: -
Exact Sciences
Jan 13, 2025
Reiterates: Buy
Price Target: $65
Current: $43.16
Upside: +50.60%
VolitionRx
Nov 22, 2024
Reiterates: Hold
Price Target: n/a
Current: $0.64
Upside: -
Nov 22, 2024
Reiterates: Speculative Buy
Price Target: $30
Current: $4.06
Upside: +638.92%
Nov 20, 2024
Reiterates: Speculative Buy
Price Target: $1.25
Current: $0.60
Upside: +106.65%
Oct 11, 2024
Reiterates: Speculative Buy
Price Target: $3
Current: $1.25
Upside: +140.00%
Oct 10, 2024
Reiterates: Speculative Buy
Price Target: $5
Current: $1.86
Upside: +168.82%
Sep 4, 2024
Reiterates: Speculative Buy
Price Target: $30
Current: $0.63
Upside: +4,646.84%
Aug 27, 2024
Reiterates: Speculative Buy
Price Target: $60
Current: $3.87
Upside: +1,450.39%
Aug 26, 2024
Reiterates: Speculative Buy
Price Target: $17
Current: $0.43
Upside: +3,865.48%
Aug 14, 2024
Reiterates: Speculative Buy
Price Target: $24
Current: $1.35
Upside: +1,677.78%
May 29, 2024
Reiterates: Speculative Buy
Price Target: $1
Current: $2.39
Upside: -58.16%
Mar 21, 2024
Reiterates: Speculative Buy
Price Target: $5
Current: $0.73
Upside: +581.11%
Nov 14, 2023
Downgrades: Hold
Price Target: n/a
Current: $1.59
Upside: -
Sep 15, 2023
Downgrades: Hold
Price Target: n/a
Current: $26.95
Upside: -
Aug 8, 2022
Initiates: Speculative Buy
Price Target: $800
Current: $3.54
Upside: +22,498.87%